Ecolab Inc.

NYSE:ECL

Chemicals - Specialty

Basic Materials
$300.68 +0.44%

+$1.18 today

Market cap
$84.33B
Beta
0.91
P/E (TTM)
36.2
EPS (TTM)
$7.47
Dividend yield
1.05%
52W Low $243.15High $309.27

Volume 1.26M

Average 1.65M

ECL EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

Ecolab Inc.NYSE: ECL

EBITDA · Q2 FY2026 · quarter ended Jun 2026

EBITDA growth accelerates

Q2 FY2026 EBITDA of $1.04B rose 5.9% year over year, ahead of the -8.7% change in trailing-twelve-month EBITDA. Sequentially, it rose 18.2% from the prior quarter. Over 3 fiscal years it compounded at +10.8% a year.

Context

  • EBITDA amounted to 21.5% of revenue in FY2025, down 2.9 pp from a year earlier.
  • EBITDA increased in 2 of the last 3 fiscal years.

What to watch

Whether EBITDA reaches the consensus estimate from 17 analysts of $3.94B (+13.8%) for the fiscal year ending Dec 2026, a step up from the -10.0% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
$1.04B+18.2% QoQ
Last fiscal yearDec 2025
$3.46B-10.0% YoY
LTMJun 2026
$3.6B-8.7% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+5.9%+46.4%+40.5 pp
1 year-10.0%+13.8%+23.8 pp
3-year CAGR+10.8%+12.6%+1.8 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

USD · from the income statement

Latest · FY2025
3.46B USD
Year-over-year change
-10.0%
4-year CAGR
+8.8%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How ECL compares with its peers on the latest reported figures

  • Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -8.7% is the 9th highest of 10, against a peer median of +8.6%.
  • EBITDA amounts to 21.4% of revenue for ECL, versus a peer median of 23.5%.
ECL Competitors
EBITDA for ECL and competitors
Company Period LTM YoY 3-year CAGR% of revenue
PGThe Procter & Gamble CompanyLTM Sep 2026$24.48B USD-1.3%+3.9%27.8%
ECLEcolab Inc.LTM Jun 2026$3.6B USD-8.7%+10.8%21.4%
CTASCintas CorporationLTM Aug 2026$3.22B USD+10.2%+12.0%27.8%
GFLGFL Environmental Inc.LTM Jun 2026CA$1.79B CAD-1.5%+7.9%25.7%
RTORentokil Initial plcFY2025$1.51B USD+52.5%+26.4%21.8%
CLXThe Clorox CompanyLTM Sep 2026$1.43B USD+8.6%+27.5%19.9%
VLTOVeralto CorporationLTM Jul 2026$1.39B USD+5.1%+3.8%24.5%
CLHClean Harbors, Inc.LTM Jun 2026$1.21B USD+9.8%+4.3%19.4%
ZWSZurn Elkay Water Solutions CorporationLTM Sep 2026$418.6M USD+14.6%+31.3%23.5%
CECOCECO Environmental Corp.LTM Jun 2026$17.71M USD-84.5%+49.7%1.9%
Peer median (excluding ECL) —+8.6%+12.0%23.5%

Competitors are the stored peer set for ECL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue12.73B14.19B15.32B15.74B16.08B
Cost of Revenue7.51B8.77B9.14B8.9B8.92B
Gross Profit5.22B5.42B6.18B6.84B7.16B
Gross Margin41.0%38.2%40.3%43.5%44.5%
Research & Development186M190M192M207M0
Selling, General & Admin3.35B3.62B3.82B4.02B4.26B
Operating Expenses3.54B3.81B4.02B4.23B4.25B
Depreciation & Amortization843.1M938.7M923.6M935.4M672.6M
EBITDA2.47B2.55B3.03B3.85B3.46B
EBITDA Margin19.4%17.9%19.8%24.4%21.5%
Operating Income1.68B1.61B2.16B2.61B2.91B
Operating Margin13.2%11.3%14.1%16.6%18.1%
Interest Income12.3M8.5M52.2M57.8M0
Interest Expense216.2M263.7M354.7M338.4M241.1M
Other Income / Expenses(270.3M)(266.1M)(405.2M)(41.2M)(364.7M)
Income Before Tax1.41B1.34B1.76B2.57B2.55B
Pre-Tax Margin11.1%9.5%11.5%16.3%15.8%
Income Tax Expense270.2M234.5M362.5M439.3M454.6M
Net Income1.13B1.09B1.37B2.11B2.08B
Net Margin8.9%7.7%9.0%13.4%12.9%
EPS (Basic)3.953.834.827.437.33
EPS (Diluted)3.913.814.797.377.28
Weighted Avg Shares286.3M285.2M285M284.3M283.3M
Weighted Avg Shares (Diluted)289.1M286.6M286.5M286.6M285.2M

Ecolab Inc.

NYSE:ECL

Intrinsic Alpha fair value

Locked

Current Price

$300.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.